Glycopyrrolate Injection, Solution
Product Images NDC 25021-796

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 25021-796). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Gly0h 0001 01)

Structural Formula (Gly0h 0001 01)
Chemical structure of glycopyrrolate, a compound with molecular formula C19H28BrNO3 and molecular weight 398.33, showing its molecular bonds and atoms.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Gly0h 0001 02)

Package Label – Principal Display Panel – Vial Label (Gly0h 0001 02)
Label for Glycopyrrolate Injection, USP 0.2 mg/mL single-dose vial by Sagent Pharmaceuticals. The label indicates intramuscular or intravenous use, contains benzyl alcohol, and is not for use in newborns. It includes an NDC code 25021-796-01 and manufacturing details.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Gly0h 0001 03)

Package Label – Principal Display Panel – Vial Label (Gly0h 0001 03)
Label for Glycopyrrolate Injection, USP 0.4 mg per 2 mL (0.2 mg per mL) single-dose vial. The label states it contains benzyl alcohol and is for intramuscular or intravenous use. Manufactured for Sagent Pharmaceuticals, Schaumburg, IL, made in India.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Gly0h 0001 04)

Package Label – Principal Display Panel – Vial Label (Gly0h 0001 04)
Label for Glycopyrrolate Injection, USP 0.2 mg/mL (1 mg per 5 mL), a multi-dose vial for intramuscular or intravenous use. The label states it contains benzyl alcohol and cautions against use in newborns. Manufactured for Sagent Pharmaceuticals, Schaumburg, IL, made in India. Includes barcode, lot, and expiration date fields.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.